June 1 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA PHARMACEUTICAL HAS ENTERED INTO A SETTLEMENT
AGREEMENT IN
US CLASS ACTION
* ANNOUNCES IT HAS ENTERED INTO A COMPREHENSIVE SETTLEMENT
AGREEMENT WITH PLAINTIFFS IN A CLASS ACTION FILED AGAINST
COMPANY IN UNITED STATES IN 2019
* A FINAL NON-APPEALABLE CLOSURE OF THIS COURT ACTION IS
EXPECTED
WITHIN ONE OR A FEW MONTHS
* ASSESSES ALTOGETHER THAT SETTLEMENT WILL NOT HAVE ANY
SIGNIFICANT IMPACT ON COMPANY'S FINANCIAL OR CASH FLOW STATUS
* CO DOES NOT INTEND TO DISCLOSE ANY FURTHER SPECIFIC
UPDATES
REGARDING CONTINUED CLOSURE OF THIS LITIGATION
Source text for Eikon: ID:nNDL7kfLRw
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))